Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Tocilizumab injection is used alone or together with other medicines to reduce the signs and symptoms of moderate to severe active rheumatoid arthritis. This medicine helps keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, infliximab) have been used and did not work well. It is a monoclonal antibody.
Tocilizumab injection is also used alone or together with glucocorticoids (steroid medicine) to treat giant cell arteritis (inflammation of the arteries). It can be used alone after stopping treatment with glucocorticoids.
Tocilizumab injection is also used to slow the rate of decline in lung function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Tocilizumab injection is also used alone or together with methotrexate to treat polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (SJIA) in children 2 years of age and older. It is also used to treat severe or life-threatening cytokine release syndrome (CRS) in adults and children 2 years of age and older.
Tocilizumab injection is also used to treat coronavirus disease 2019 (COVID-19) in hospitalized patients who are receiving systemic corticosteroids and requiring supplemental oxygen and mechanical ventilation.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: